Companies /Healthcare

Delcath Systems Inc

NASDAQ: DCTH Medical Devices
$16.39
▼ $0.01 (−0.06%) today
Markets closed · 7:22am ET
Today · % change

Fundamentals

Market Cap
$568.7M
P/E Ratio
1,639.0
Profit Margin
0.6%
Revenue (TTM)
$95.4M
EPS (TTM)
$0.01
52-Week Range
$8 – $17
Street Target
$24.00

About Delcath Systems

Delcath Systems, Inc., an interventional oncology company, focuses on the treatment of primary and metastatic liver cancers in the United States and Europe. The company is headquartered in New York, New York.

DCTH Coverage

6:20am ET
Investing

The 6 Most Shorted Nasdaq Stocks

Short sellers shied away from the two most shorted stocks traded on the Nasdaq between the latest settlement dates, but they moved on other short seller favorites.

Trey Thoelcke
4:27pm ET
Investing

Stock Market Today: Big Winners & Losers for Tuesday

thinkstockHere are the five biggest gaining stocks in today’s U.S. markets at closing: Transition Therapeutics Inc. (NASDAQ: TTHI) is up 37.8% at $3.10. Digital Ally Inc. (NASDAQ: DGLY) is up 35.8% at…

Paul Ausick
1:45pm ET
Investing

5 Unusual Low-Priced Major Volume Spikes

ThinkstockLow-priced stocks can often have active volume already, and quite often due to perhaps nothing more than their low share price when news is announced. 24/7 Wall St. already tracked the active…

Jon C. Ogg
10:27am ET
Investing

Today’s Market Winners and Losers

Photo by Spencer Platt/Getty ImagesThe stock market is mixed Monday, with the Dow Jones Industrial Average up 0.06%, the Nasdaq down 0.09% and the S&P 500 flat. Today’s big winner is a…

247sam